KRAS and colorectal carcinoma: This is an in vitro diagnostic reagent that is used in rtPCR to detect seven somatic mutations in the human KRAS gene (G12A, G12D, G12R, G12C, G12S, and G12V in codon 12, and G13D in codon 13) in patients with CRC.